GlòriaG.Durà-VilàGlòriaG., RolandR.LittlewoodRolandR., GerardG.LeaveyGerardG., Depression and the medicalization of sadness: conceptualization and recommended help-seeking, „The International Journal of Social Psychiatry”, 59 (2), 2013, s. 165–175, DOI: 10.1177/0020764011430037, PMID: 22187003, PMCID: PMC4107836.
PawełP.RodzińskiPawełP. i inni, Redukcja myśli samobójczych u pacjentów poddanych psychoterapii w dziennym oddziale leczenia nerwic i zaburzeń behawioralnych a zgłaszane przez nich przed rozpoczęciem hospitalizacji objawy nerwicowe / Reduction of suicidal ideation in patients undergoing psychotherapy in the day hospital for the treatment of neurotic and behavioral disorders and neurotic symptoms reported by them before the hospitalization, „Psychiatria Polska”, 4, 49, 2015, s. 847–864, DOI: 10.12740/PP/OnlineFirst/32223, PMID: 26488359.
MarlenaM.BartczakMarlenaM., BarbaraB.BokusBarbaraB., Cognitive representations (Metaphorical Conceptualizations) of past, future, joy, sadness and happiness in depressive and non-depressive subjects: cognitive distortions in depression at the level of notion, „Journal of Psycholinguistic Research”, 44 (2), 2015, s. 159–185, DOI: 10.1007/s10936-014-9286-6, PMID: 24510583, PMCID: PMC4357654.
Cheryl L.Ch.L.BeselerCheryl L.Ch.L. i inni, Depression and pesticide exposures among private pesticide applicators enrolled in the Agricultural Health Study, „Environmental Health Perspectives”, 116 (12), 2008, s. 1713–1719, DOI: 10.1289/ehp.11091, PMID: 19079725, PMCID: PMC2599768.
Stephen M.S.M.StahlStephen M.S.M. i inni, A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor, „Primary Care Companion to the Journal of Clinical Psychiatry”, 6 (4), 2004, s. 159–166, DOI: 10.4088/PCC.v06n0403, PMID: 15361919, PMCID: PMC514842.
SidneyS.ZisookSidneyS. i inni, Use of bupropion in combination with serotonin reuptake inhibitors, „Biological Psychiatry”, 59 (3), 2006, s. 203–210, DOI: 10.1016/j.biopsych.2005.06.027, PMID: 16165100.
Jerzy A.J.A.SobańskiJerzy A.J.A. i inni, Are neurotic personality traits and neurotic symptoms intensity associated with suicidal thoughts reported by patients of a day hospital for neurotic disorders? / Czy cechy osobowości i nasilenie objawów nerwicowych wiążą się ze sprawozdawaniem myśli samobójczych u pacjentów dziennego oddziału leczenia zaburzeń nerwicowych?, „Psychiatria Polska”, 49 (6), 2015, s. 1343–1358, DOI: 10.12740/psychiatriapolska.pl/online-first/5, PMID: 26909406(ang. • pol.).
Toshi A.T.A.FurukawaToshi A.T.A. i inni, Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies, „The Lancet. Psychiatry”, 3 (11), 2016, s. 1059–1066, DOI: 10.1016/S2215-0366(16)30307-8.
BruceB.ArrollBruceB. i inni, Antidepressants for treatment of depression in primary care: a systematic review and meta-analysis, „Journal of Primary Health Care”, 8 (4), 2016, s. 325–334, DOI: 10.1071/HC16008, PMID: 29530157.
KlausK.LindeKlausK. i inni, Questionable assumptions hampered interpretation of a network meta-analysis of primary care depression treatments, „Journal of Clinical Epidemiology”, 71, 2016, s. 86–96, DOI: 10.1016/j.jclinepi.2015.10.010, PMID: 26524496.
LeventeL.KristonLeventeL. i inni, Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis, „Depression and Anxiety”, 31 (8), 2014, s. 621–630, DOI: 10.1002/da.22236, PMID: 24448972.
KrisnaK.PatelKrisnaK. i inni, Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant, „Therapeutic Advances in Psychopharmacology”, 6 (2), 2016, s. 99–144, DOI: 10.1177/2045125316629071, PMID: 27141292, PMCID: PMC4837968.
AtsuoA.NakagawaAtsuoA. i inni, Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants. a systematic review and meta-analysis, „CNS drugs”, 22 (7), 2008, s. 587–602, DOI: 10.2165/00023210-200822070-00004, PMID: 18547127.
MarcoM.SolmiMarcoM. i inni, Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials, „CNS Spectrums”, 21 (5), 2016, s. 403–418, DOI: 10.1017/S1092852916000523, PMID: 27686028.
Sheng-MinS.M.WangSheng-MinS.M. i inni, A review of current evidence for acetyl-l-carnitine in the treatment of depression, „Journal of Psychiatric Research”, 53, 2014, s. 30–37, DOI: 10.1016/j.jpsychires.2014.02.005, PMID: 24607292.
George A.G.A.EbyGeorge A.G.A., Karen L.K.L.EbyKaren L.K.L., Magnesium for treatment-resistant depression: a review and hypothesis, „Medical Hypotheses”, 74 (4), 2010, s. 649–660, DOI: 10.1016/j.mehy.2009.10.051, ISSN0306-9877.
Miguel ÁngelM.Á.Martínez-GonzálezMiguel ÁngelM.Á., AlmudenaA.Sánchez-VillegasAlmudenaA., Magnesium intake and depression: the SUN cohort, „Magnesium Research”, 29 (3), 2016, s. 102–111, DOI: 10.1684/mrh.2016.0409, ISSN1952-4021, PMID: 27910807.
XinyuX.ZhouXinyuX. i inni, Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-yesistant depression, „The Journal of Clinical Psychiatry”, 76 (4), 2015, e487–e498, DOI: 10.4088/jcp.14r09204, PMID: 25919841.
MichaelM.BauerMichaelM. i inni, Role of Lithium Augmentation in the Management of Major Depressive Disorder, „CNS Drugs”, 28 (4), 2014, s. 331–342, DOI: 10.1007/s40263-014-0152-8.
EstelaE.SalagreEstelaE. i inni, Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials, „Journal of Affective Disorders”, 200, 2016, s. 235–242, DOI: 10.1016/j.jad.2016.04.047, PMID: 27148902.
Kyoung-SaeK.S.NaKyoung-SaeK.S. i inni, Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis, „Progress in Neuro-Psychopharmacology and Biological Psychiatry”, 48, 2014, s. 79–85, DOI: 10.1016/j.pnpbp.2013.09.006, PMID: 24056287.
TaroT.KishiTaroT., ShinjiS.MatsunagaShinjiS., NakaoN.IwataNakaoN., Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials, „European Archives of Psychiatry and Clinical Neuroscience”, 267 (2), 2016, s. 149–161, DOI: 10.1007/s00406-016-0706-5, PMID: 27318835.
RuixueR.HuangRuixueR., KeK.WangKeK., JiananJ.HuJiananJ., Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials, „Nutrients”, 8 (8), 2016, art. nr e483, DOI: 10.3390/nu8080483, PMID: 27509521, PMCID: PMC4997396.
P.P.CuijpersP.P. i inni, Comparison of psychotherapies for adult depression to pill placebo control groups: a meta-analysis, „Psychological Medicine”, 44 (4), 2014, s. 685–695, DOI: 10.1017/S0033291713000457, PMID: 23552610.
Joseph K.J.K.CarpenterJoseph K.J.K. i inni, Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials, „Depression and Anxiety”, 35 (6), 2018, s. 502–514, DOI: 10.1002/da.22728, PMID: 29451967, PMCID: PMC5992015.
PimP.CuijpersPimP. i inni, Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression, „Depression and Anxiety”, 34 (3), 2016, s. 246–256, DOI: 10.1002/da.22580, PMID: 27921338.
Dina MD.M.SzteinDina MD.M. i inni, Efficacy of cognitive behavioural therapy delivered over the Internet for depressive symptoms: A systematic review and meta-analysis, „Journal of Telemedicine and Telecare”, 2017, DOI: 10.1177/1357633x17717402, PMID: 28696153.
JosephineJ.KönigbauerJosephineJ. i inni, Internet- and mobile-based depression interventions for people with diagnosed depression: a systematic review and meta-analysis, „Journal of Affective Disorders”, 223, 2017, s. 28–40, DOI: 10.1016/j.jad.2017.07.021, PMID: 28715726.
PimP.CuijpersPimP. i inni, Problem-solving therapy for adult depression: an updated meta-analysis, „European Psychiatry”, 48, 2018, s. 27–37, DOI: 10.1016/j.eurpsy.2017.11.006, PMID: 29331596.
Larry C.L.C.LyonsLarry C.L.C., Paul J.P.J.WoodsPaul J.P.J., The efficacy of rational-emotive therapy: a quantitative review of the outcome research, „Clinical Psychology Review”, 11 (4), 1991, s. 357–369, DOI: 10.1016/0272-7358(91)90113-9.
M. Feijo deM.F.MelloM. Feijo deM.F. i inni, A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders, „European Archives of Psychiatry and Clinical Neuroscience”, 255 (2), 2004, s. 75–82, DOI: 10.1007/s00406-004-0542-x, PMID: 15812600.
EllenE.DriessenEllenE. i inni, The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update, „Clinical Psychology Review”, 42, 2015, s. 1–15, DOI: 10.1016/j.cpr.2015.07.004, PMID: 26281018.
D. MartinD.M.KivlighanD. MartinD.M. i inni, The enduring effects of psychodynamic treatments vis-à-vis alternative treatments: A multilevel longitudinal meta-analysis, „Clinical Psychology Review”, 40, 2015, s. 1–14, DOI: 10.1016/j.cpr.2015.05.003, PMID: 26042927.
PeterP.LilliengrenPeterP. i inni, Efficacy of experiential dynamic therapy for psychiatric conditions: a meta-analysis of randomized controlled trials, „Psychotherapy”, 53 (1), 2016, s. 90–104, DOI: 10.1037/pst0000024, PMID: 26390013.
AnnaA.HuguetAnnaA. i inni, A systematic review and meta-analysis on the efficacy of Internet-delivered behavioral activation, „Journal of Affective Disorders”, 235, 2018, s. 27–38, DOI: 10.1016/j.jad.2018.02.073, PMID: 29649708.
IsabelleI.Soucy-ChartierIsabelleI., Martin D.M.D.ProvencherMartin D.M.D., Behavioural activation for depression: efficacy, effectiveness and dissemination, „Journal of Affective Disorders”, 145 (3), 2013, s. 292–299, DOI: 10.1016/j.jad.2012.07.023, PMID: 22884236.
Stefan G.S.G.HofmannStefan G.S.G. i inni, The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review, „Journal of Consulting and Clinical Psychology”, 78 (2), 2010, s. 169–183, DOI: 10.1037/a0018555, PMID: 20350028, PMCID: PMC2848393.
AlbertoA.ChiesaAlbertoA., AlessandroA.SerrettiAlessandroA., Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis, „Psychiatry Research”, 187 (3), 2011, s. 441–453, DOI: 10.1016/j.psychres.2010.08.011, PMID: 20846726.
BassamB.KhouryBassamB. i inni, Mindfulness-based therapy: a comprehensive meta-analysis, „Clinical Psychology Review”, 33 (6), 2013, s. 763–771, DOI: 10.1016/j.cpr.2013.05.005, PMID: 23796855.
Mark B.M.B.PowersMark B.M.B., Maarten B. Zum Vörde SiveM.B.Z.V.S.VördingMaarten B. Zum Vörde SiveM.B.Z.V.S., Paul M.G.P.M.G.EmmelkampPaul M.G.P.M.G., Acceptance and Commitment Therapy: a meta-analytic review, „Psychotherapy and Psychosomatics”, 78 (2), 2009, s. 73–80, DOI: 10.1159/000190790, PMID: 19142046.
Lars-GöranL.G.ÖstLars-GöranL.G., The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-analysis, „Behaviour Research and Therapy”, 61, 2014, s. 105–121, DOI: 10.1016/j.brat.2014.07.018, PMID: 25193001.
ThomasT.HackerThomasT., PaulP.StonePaulP., AngusA.MacBethAngusA., Acceptance and commitment therapy – do we know enough? Cumulative and sequential meta-analyses of randomized controlled trials, „Journal of Affective Disorders”, 190, 2016, s. 551–565, DOI: 10.1016/j.jad.2015.10.053, PMID: 26571105.
NicolineN.NormannNicolineN., Arnold A.P. vanA.A.P.EmmerikArnold A.P. vanA.A.P., NexhmedinN.MorinaNexhmedinN., The efficacy of metacognitive therapy for anxiety and depression: a meta-analytic review, „Depression and Anxiety”, 31 (5), 2014, s. 402–411, DOI: 10.1002/da.22273, PMID: 24756930.
Samantha A.S.A.MasleySamantha A.S.A. i inni, A systematic review of the evidence base for schema therapy, „Cognitive Behaviour Therapy”, 41 (3), 2012, s. 185–202, DOI: 10.1080/16506073.2011.614274, PMID: 22074317.
Lauren S.L.S.HallionLauren S.L.S., Ayelet MeronA.M.RuscioAyelet MeronA.M., A meta-analysis of the effect of cognitive bias modification on anxiety and depression, „Psychological Bulletin”, 137 (6), 2011, s. 940–958, DOI: 10.1037/a0024355, PMID: 21728399.
Cuijpers i inni, Psychological treatment of depression: Results of a series of meta-analyses, „Nordic Journal of Psychiatry”, 65 (6), 2011, s. 354–364, DOI: 10.3109/08039488.2011.596570, PMID: 21770842.
Ioana A.I.A.CristeaIoana A.I.A. i inni, Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: Meta-analysis, „The British Journal of Psychiatry”, 210 (1), 2017, s. 16–23, DOI: 10.1192/bjp.bp.115.179275, PMID: 27810891.
JohnJ.HunsleyJohnJ., KatherineK.ElliottKatherineK., ZoéZ.TherrienZoéZ., The efficacy and effectiveness of psychological treatments for mood, anxiety, and related disorders, „Canadian Psychology / Psychologie canadienne”, 55 (3), 2014, s. 161–176, DOI: 10.1037/a003693.
David F.D.F.TolinDavid F.D.F., Can cognitive behavioral therapy for anxiety and depression be improved with pharmacotherapy? A meta-analysis, „Psychiatric Clinics of North America”, 40 (4), 2017, s. 715–738, DOI: 10.1016/j.psc.2017.08.007, PMID: 29080596.
ChristophCh.FlückigerChristophCh. i inni, Enduring effects of evidence-based psychotherapies in acute depression and anxiety disorders versus treatment as usual at follow-up – A longitudinal meta-analysis, „Clinical Psychology Review”, 34 (5), 2014, s. 367–375, DOI: 10.1016/j.cpr.2014.05.001, PMID: 24927168.
EiriniE.KaryotakiEiriniE. i inni, The long-term efficacy of acute-phase psychotherapy for depression: a meta-analysis of randomized trials, „Depression and Anxiety”, 33 (5), 2016, s. 370–383, DOI: 10.1002/da.22491, PMID: 27000501.
DaliaD.Al-KarawiDaliaD., LuqmanL.JubairLuqmanL., Bright light therapy for nonseasonal depression: Meta-analysis of clinical trials, „Journal of Affective Disorders”, 198, 2016, s. 64–71, DOI: 10.1016/j.jad.2016.03.016, PMID: 27011361.
M.T.M.T.BerlimM.T.M.T., F. Van denF.V.EyndeF. Van denF.V., Z.J.Z.J.DaskalakisZ.J.Z.J., A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression, „Psychological Medicine”, 43 (11), 2013, s. 2245–2254, DOI: 10.1017/S0033291712002802, PMID: 23200131.
Jian-junJ.ChenJian-junJ. i inni, Bilateral vs. unilateral repetitive transcranial magnetic stimulation in treating major depression: A meta-analysis of randomized controlled trials, „Psychiatry Research”, 219 (1), 2014, s. 51–57, DOI: 10.1016/j.psychres.2014.05.010, PMID: 24889845.
Jian-junJ.ChenJian-junJ. i inni, Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: A systematic review and multiple-treatments meta-analysis, „Behavioural Brain Research”, 320, 2017, s. 30–36, DOI: 10.1016/j.bbr.2016.11.028, PMID: 27876667.
Jean-PascalJ.P.LefaucheurJean-PascalJ.P. i inni, Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS), „Clinical Neurophysiology”, 128 (1), 2017, s. 56–92, DOI: 10.1016/j.clinph.2016.10.087, PMID: 27866120.
Donel M.D.M.MartinDonel M.D.M. i inni, Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: An individual patient data meta-analysis of randomised, sham-controlled trials, „Neuroscience & Biobehavioral Reviews”, 90, 2018, s. 137–145, DOI: 10.1016/j.neubiorev.2018.04.008, PMID: 29660416.
SiriS.KvamSiriS. i inni, Exercise as a treatment for depression: A meta-analysis, „Journal of Affective Disorders”, 202, 2016, s. 67–86, DOI: 10.1016/j.jad.2016.03.063, PMID: 27253219.
Julie MagnoJ.M.ZitoJulie MagnoJ.M. i inni, Rising prevalence of antidepressants among US youths, „Pediatrics”, 109 (5), 2002, s. 721–727, DOI: 10.1542/peds.109.5.721, PMID: 11986427.
João MaurícioJ.M.Castaldelli-MaiaJoão MaurícioJ.M. i inni, Perceptions of and attitudes toward antidepressants: stigma attached to their use-a review, „The Journal of Nervous and Mental Disease”, 199 (11), 2011, s. 866–871, DOI: 10.1097/NMD.0b013e3182388950, PMID: 22048139.
MagdalenaM.Podogrodzka-NiellMagdalenaM., MagdalenaM.TyszkowskaMagdalenaM., Stygmatyzacja na drodze zdrowienia w chorobach psychicznych – czynniki związane z funkcjonowaniem społecznym / Stigmatization on the way to recovery in mental illness – the factors associated with social functioning, „Psychiatria Polska”, 48 (6), 2014, s. 1201–1211, DOI: 10.12740/PP/20364, PMID: 25717489(pol. • ang.).
doi.org
S. Negoias, I. Croy, J. Gerber, S. Puschmann i inni. Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. „Neuroscience”. 169 (1), s. 415–421, 2010. DOI: 10.1016/j.neuroscience.2010.05.012. PMID: 20472036.
M.K. Harrison. Lindemann’s crisis theory and Dabrowski’s positive disintegration theory. A comparative analysis. „Perspect Psychiatr Care”. 3 (6), s. 8–13, 1965. DOI: 10.1111/j.1744-6163.1965.tb01446.x. PMID: 5174396.
P.W. Andrews, J.A. Thomson. The bright side of being blue: depression as an adaptation for analyzing complex problems. „Psychol Rev”. 116 (3), s. 620–654, 2009. DOI: 10.1037/a0016242. PMID: 19618990. PMCID: PMC2734449.
D. Nettle. Evolutionary origins of depression: a review and reformulation. „J Affect Disord”. 81 (2), s. 91–102, 2004. DOI: 10.1016/j.jad.2003.08.009. PMID: 15306134.
M.E. Stewart, L. Barnard, J. Pearson, R. Hasan i inni. Presentation of depression in autism and Asperger syndrome: a review. „Autism”. 10 (1), s. 103–116, 2006. DOI: 10.1177/1362361306062013. PMID: 16522713.
M.M. Amr, Z.S. Halim, S.S. Moussa. Psychiatric disorders among Egyptian pesticide applicators and formulators. „Environ Res”. 73 (1–2), s. 193–199, 1997. DOI: 10.1006/enrs.1997.3744. PMID: 9311547.
C.L. Beseler, L. Stallones. A cohort study of pesticide poisoning and depression in Colorado farm residents. „Ann Epidemiol”. 18 (10), s. 768–774, 2008. DOI: 10.1016/j.annepidem.2008.05.004. PMID: 18693039.
A. Meyer, S. Koifman, R.J. Koifman, J.C. Moreira i inni. Mood disorders hospitalizations, suicide attempts, and suicide mortality among agricultural workers and residents in an area with intensive use of pesticides in Brazil. „J Toxicol Environ Health A”. 73 (13–14), s. 866–877, 2010. DOI: 10.1080/15287391003744781. PMID: 20563920.
T. Parrón, A.F. Hernández, E. Villanueva. Increased risk of suicide with exposure to pesticides in an intensive agricultural area. A 12-year retrospective study. „Forensic Sci Int”. 79 (1), s. 53–63, 1996. DOI: 10.1016/0379-0738(96)01895-6. PMID: 8635774.
Fietta P, Fietta P, Delsante G. Central nervous system effects of natural and synthetic glucocorticoids. „Psychiatry Clin Neurosci.”. 63 (5), s. 613–622, 2009. DOI: 10.1111/j.1440-1819.2009.02005.x.. PMID: 19788629.
Udina M, Castellví P, Moreno-España J, Navinés R, Valdés M, Forns X, Langohr K, Solà R, Vieta E, Martín-Santos R. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. „J Clin Psychiatry”. 73 (8), s. 1128–1138, 2012. DOI: 10.4088/JCP.12r07694.. PMID: 22967776.
B.I. Yerevanian, R.J. Koek, J.D. Feusner, S. Hwang i inni. Antidepressants and suicidal behaviour in unipolar depression. „Acta Psychiatr Scand”. 110 (6), s. 452–458, 2004. DOI: 10.1111/j.1600-0447.2004.00437.x. PMID: 15521830.
F.N. Jacka, S. Overland, R. Stewart, G.S. Tell i inni. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. „Aust N Z J Psychiatry”. 43 (1), s. 45–52, 2009. DOI: 10.1080/00048670802534408. PMID: 19085527.
G.A. Eby, K.L. Eby. Rapid recovery from major depression using magnesium treatment. „Med Hypotheses”. 67 (2), s. 362–370, 2006. DOI: 10.1016/j.mehy.2006.01.047. PMID: 16542786.
B. Dierckx, W.T. Heijnen, W.W. van den Broek, T.K. Birkenhäger. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. „Bipolar Disord”. 14 (2), s. 146–150, 2012. DOI: 10.1111/j.1399-5618.2012.00997.x. PMID: 22420590.
Anna Maratos, Christian Gold, Xu Wang et al.. Music therapy for depression. „Cochrane Database of Systematic Reviews”, s. 1059–1066, 2008. DOI: 10.1002/14651858.CD004517.pub3. PMID: 29144545.Sprawdź autora:1.
Ehud Bodner, Iulian Iancu, Avi Gilboa et al.. Finding words for emotions: The reactions of patients with major depressive disorder towards various musical excerpts. „The Arts in Psychotherapy”. 34 (2), s. 142–150, 2007. DOI: 10.1016/j.aip.2006.12.002.Sprawdź autora:1.
J. Luigjes, B.P. de Kwaasteniet, P.P. de Koning, M.S. Oudijn i inni. Surgery for psychiatric disorders. „World Neurosurg”. 80 (3–4), s. S31.e17-S31.e28, 2013. DOI: 10.1016/j.wneu.2012.03.009. PMID: 22465369.
S. Ilyas, J. Moncrieff. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. „Br J Psychiatry”. 200 (5), s. 393–398, 2012. DOI: 10.1192/bjp.bp.111.104257. PMID: 22442100.
W.A. Vega, M.A. Rodriguez, A. Ang. Addressing stigma of depression in Latino primary care patients. „Gen Hosp Psychiatry”. 32 (2). s. 182–191. DOI: 10.1016/j.genhosppsych.2009.10.008. PMID: 20302993.
M.C. Angermeyer, M. Beck, S. Dietrich, A. Holzinger. The stigma of mental illness: patients’ anticipations and experiences. „Int J Soc Psychiatry”. 50 (2), s. 153–162, 2004. DOI: 10.1177/0020764004043115. PMID: 15293432.
GlòriaG.Durà-VilàGlòriaG., RolandR.LittlewoodRolandR., GerardG.LeaveyGerardG., Depression and the medicalization of sadness: conceptualization and recommended help-seeking, „The International Journal of Social Psychiatry”, 59 (2), 2013, s. 165–175, DOI: 10.1177/0020764011430037, PMID: 22187003, PMCID: PMC4107836.
PawełP.RodzińskiPawełP. i inni, Redukcja myśli samobójczych u pacjentów poddanych psychoterapii w dziennym oddziale leczenia nerwic i zaburzeń behawioralnych a zgłaszane przez nich przed rozpoczęciem hospitalizacji objawy nerwicowe / Reduction of suicidal ideation in patients undergoing psychotherapy in the day hospital for the treatment of neurotic and behavioral disorders and neurotic symptoms reported by them before the hospitalization, „Psychiatria Polska”, 4, 49, 2015, s. 847–864, DOI: 10.12740/PP/OnlineFirst/32223, PMID: 26488359.
MarlenaM.BartczakMarlenaM., BarbaraB.BokusBarbaraB., Cognitive representations (Metaphorical Conceptualizations) of past, future, joy, sadness and happiness in depressive and non-depressive subjects: cognitive distortions in depression at the level of notion, „Journal of Psycholinguistic Research”, 44 (2), 2015, s. 159–185, DOI: 10.1007/s10936-014-9286-6, PMID: 24510583, PMCID: PMC4357654.
H.S. Akiskal, O. Pinto. The evolving bipolar spectrum. Prototypes I, II, III, and IV. „Psychiatr Clin North Am”. 22 (3), s. 517–534, vii, 1999. PMID: 10550853.
S. Negoias, I. Croy, J. Gerber, S. Puschmann i inni. Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. „Neuroscience”. 169 (1), s. 415–421, 2010. DOI: 10.1016/j.neuroscience.2010.05.012. PMID: 20472036.
Kazimierz Dąbrowski. Remarks on typology based on the theory of positive disintegration. „Ann Med Psychol (Paris)”. 118 (2), s. 401–406, 1960. PMID: 13719255.
M.K. Harrison. Lindemann’s crisis theory and Dabrowski’s positive disintegration theory. A comparative analysis. „Perspect Psychiatr Care”. 3 (6), s. 8–13, 1965. DOI: 10.1111/j.1744-6163.1965.tb01446.x. PMID: 5174396.
P.W. Andrews, J.A. Thomson. The bright side of being blue: depression as an adaptation for analyzing complex problems. „Psychol Rev”. 116 (3), s. 620–654, 2009. DOI: 10.1037/a0016242. PMID: 19618990. PMCID: PMC2734449.
D. Nettle. Evolutionary origins of depression: a review and reformulation. „J Affect Disord”. 81 (2), s. 91–102, 2004. DOI: 10.1016/j.jad.2003.08.009. PMID: 15306134.
M.E. Stewart, L. Barnard, J. Pearson, R. Hasan i inni. Presentation of depression in autism and Asperger syndrome: a review. „Autism”. 10 (1), s. 103–116, 2006. DOI: 10.1177/1362361306062013. PMID: 16522713.
M.M. Amr, Z.S. Halim, S.S. Moussa. Psychiatric disorders among Egyptian pesticide applicators and formulators. „Environ Res”. 73 (1–2), s. 193–199, 1997. DOI: 10.1006/enrs.1997.3744. PMID: 9311547.
Cheryl L.Ch.L.BeselerCheryl L.Ch.L. i inni, Depression and pesticide exposures among private pesticide applicators enrolled in the Agricultural Health Study, „Environmental Health Perspectives”, 116 (12), 2008, s. 1713–1719, DOI: 10.1289/ehp.11091, PMID: 19079725, PMCID: PMC2599768.
C.L. Beseler, L. Stallones. A cohort study of pesticide poisoning and depression in Colorado farm residents. „Ann Epidemiol”. 18 (10), s. 768–774, 2008. DOI: 10.1016/j.annepidem.2008.05.004. PMID: 18693039.
A. Meyer, S. Koifman, R.J. Koifman, J.C. Moreira i inni. Mood disorders hospitalizations, suicide attempts, and suicide mortality among agricultural workers and residents in an area with intensive use of pesticides in Brazil. „J Toxicol Environ Health A”. 73 (13–14), s. 866–877, 2010. DOI: 10.1080/15287391003744781. PMID: 20563920.
T. Parrón, A.F. Hernández, E. Villanueva. Increased risk of suicide with exposure to pesticides in an intensive agricultural area. A 12-year retrospective study. „Forensic Sci Int”. 79 (1), s. 53–63, 1996. DOI: 10.1016/0379-0738(96)01895-6. PMID: 8635774.
Fietta P, Fietta P, Delsante G. Central nervous system effects of natural and synthetic glucocorticoids. „Psychiatry Clin Neurosci.”. 63 (5), s. 613–622, 2009. DOI: 10.1111/j.1440-1819.2009.02005.x.. PMID: 19788629.
Udina M, Castellví P, Moreno-España J, Navinés R, Valdés M, Forns X, Langohr K, Solà R, Vieta E, Martín-Santos R. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. „J Clin Psychiatry”. 73 (8), s. 1128–1138, 2012. DOI: 10.4088/JCP.12r07694.. PMID: 22967776.
Stephen M.S.M.StahlStephen M.S.M. i inni, A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor, „Primary Care Companion to the Journal of Clinical Psychiatry”, 6 (4), 2004, s. 159–166, DOI: 10.4088/PCC.v06n0403, PMID: 15361919, PMCID: PMC514842.
SidneyS.ZisookSidneyS. i inni, Use of bupropion in combination with serotonin reuptake inhibitors, „Biological Psychiatry”, 59 (3), 2006, s. 203–210, DOI: 10.1016/j.biopsych.2005.06.027, PMID: 16165100.
Jerzy A.J.A.SobańskiJerzy A.J.A. i inni, Are neurotic personality traits and neurotic symptoms intensity associated with suicidal thoughts reported by patients of a day hospital for neurotic disorders? / Czy cechy osobowości i nasilenie objawów nerwicowych wiążą się ze sprawozdawaniem myśli samobójczych u pacjentów dziennego oddziału leczenia zaburzeń nerwicowych?, „Psychiatria Polska”, 49 (6), 2015, s. 1343–1358, DOI: 10.12740/psychiatriapolska.pl/online-first/5, PMID: 26909406(ang. • pol.).
B.I. Yerevanian, R.J. Koek, J.D. Feusner, S. Hwang i inni. Antidepressants and suicidal behaviour in unipolar depression. „Acta Psychiatr Scand”. 110 (6), s. 452–458, 2004. DOI: 10.1111/j.1600-0447.2004.00437.x. PMID: 15521830.
F.N. Jacka, S. Overland, R. Stewart, G.S. Tell i inni. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. „Aust N Z J Psychiatry”. 43 (1), s. 45–52, 2009. DOI: 10.1080/00048670802534408. PMID: 19085527.
K. Wilson, V. Brakoulias. Magnesium intake and depression. „Aust N Z J Psychiatry”. 43 (6), s. 580, 2009. PMID: 19452662.
G.A. Eby, K.L. Eby. Rapid recovery from major depression using magnesium treatment. „Med Hypotheses”. 67 (2), s. 362–370, 2006. DOI: 10.1016/j.mehy.2006.01.047. PMID: 16542786.
BruceB.ArrollBruceB. i inni, Antidepressants for treatment of depression in primary care: a systematic review and meta-analysis, „Journal of Primary Health Care”, 8 (4), 2016, s. 325–334, DOI: 10.1071/HC16008, PMID: 29530157.
KlausK.LindeKlausK. i inni, Questionable assumptions hampered interpretation of a network meta-analysis of primary care depression treatments, „Journal of Clinical Epidemiology”, 71, 2016, s. 86–96, DOI: 10.1016/j.jclinepi.2015.10.010, PMID: 26524496.
LeventeL.KristonLeventeL. i inni, Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis, „Depression and Anxiety”, 31 (8), 2014, s. 621–630, DOI: 10.1002/da.22236, PMID: 24448972.
KrisnaK.PatelKrisnaK. i inni, Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant, „Therapeutic Advances in Psychopharmacology”, 6 (2), 2016, s. 99–144, DOI: 10.1177/2045125316629071, PMID: 27141292, PMCID: PMC4837968.
AtsuoA.NakagawaAtsuoA. i inni, Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants. a systematic review and meta-analysis, „CNS drugs”, 22 (7), 2008, s. 587–602, DOI: 10.2165/00023210-200822070-00004, PMID: 18547127.
MarcoM.SolmiMarcoM. i inni, Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials, „CNS Spectrums”, 21 (5), 2016, s. 403–418, DOI: 10.1017/S1092852916000523, PMID: 27686028.
Sheng-MinS.M.WangSheng-MinS.M. i inni, A review of current evidence for acetyl-l-carnitine in the treatment of depression, „Journal of Psychiatric Research”, 53, 2014, s. 30–37, DOI: 10.1016/j.jpsychires.2014.02.005, PMID: 24607292.
Miguel ÁngelM.Á.Martínez-GonzálezMiguel ÁngelM.Á., AlmudenaA.Sánchez-VillegasAlmudenaA., Magnesium intake and depression: the SUN cohort, „Magnesium Research”, 29 (3), 2016, s. 102–111, DOI: 10.1684/mrh.2016.0409, ISSN1952-4021, PMID: 27910807.
XinyuX.ZhouXinyuX. i inni, Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-yesistant depression, „The Journal of Clinical Psychiatry”, 76 (4), 2015, e487–e498, DOI: 10.4088/jcp.14r09204, PMID: 25919841.
EstelaE.SalagreEstelaE. i inni, Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials, „Journal of Affective Disorders”, 200, 2016, s. 235–242, DOI: 10.1016/j.jad.2016.04.047, PMID: 27148902.
Kyoung-SaeK.S.NaKyoung-SaeK.S. i inni, Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis, „Progress in Neuro-Psychopharmacology and Biological Psychiatry”, 48, 2014, s. 79–85, DOI: 10.1016/j.pnpbp.2013.09.006, PMID: 24056287.
TaroT.KishiTaroT., ShinjiS.MatsunagaShinjiS., NakaoN.IwataNakaoN., Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials, „European Archives of Psychiatry and Clinical Neuroscience”, 267 (2), 2016, s. 149–161, DOI: 10.1007/s00406-016-0706-5, PMID: 27318835.
RuixueR.HuangRuixueR., KeK.WangKeK., JiananJ.HuJiananJ., Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials, „Nutrients”, 8 (8), 2016, art. nr e483, DOI: 10.3390/nu8080483, PMID: 27509521, PMCID: PMC4997396.
P.P.CuijpersP.P. i inni, Comparison of psychotherapies for adult depression to pill placebo control groups: a meta-analysis, „Psychological Medicine”, 44 (4), 2014, s. 685–695, DOI: 10.1017/S0033291713000457, PMID: 23552610.
Joseph K.J.K.CarpenterJoseph K.J.K. i inni, Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials, „Depression and Anxiety”, 35 (6), 2018, s. 502–514, DOI: 10.1002/da.22728, PMID: 29451967, PMCID: PMC5992015.
PimP.CuijpersPimP. i inni, Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression, „Depression and Anxiety”, 34 (3), 2016, s. 246–256, DOI: 10.1002/da.22580, PMID: 27921338.
Dina MD.M.SzteinDina MD.M. i inni, Efficacy of cognitive behavioural therapy delivered over the Internet for depressive symptoms: A systematic review and meta-analysis, „Journal of Telemedicine and Telecare”, 2017, DOI: 10.1177/1357633x17717402, PMID: 28696153.
JosephineJ.KönigbauerJosephineJ. i inni, Internet- and mobile-based depression interventions for people with diagnosed depression: a systematic review and meta-analysis, „Journal of Affective Disorders”, 223, 2017, s. 28–40, DOI: 10.1016/j.jad.2017.07.021, PMID: 28715726.
M. Feijo deM.F.MelloM. Feijo deM.F. i inni, A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders, „European Archives of Psychiatry and Clinical Neuroscience”, 255 (2), 2004, s. 75–82, DOI: 10.1007/s00406-004-0542-x, PMID: 15812600.
EllenE.DriessenEllenE. i inni, The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis update, „Clinical Psychology Review”, 42, 2015, s. 1–15, DOI: 10.1016/j.cpr.2015.07.004, PMID: 26281018.
D. MartinD.M.KivlighanD. MartinD.M. i inni, The enduring effects of psychodynamic treatments vis-à-vis alternative treatments: A multilevel longitudinal meta-analysis, „Clinical Psychology Review”, 40, 2015, s. 1–14, DOI: 10.1016/j.cpr.2015.05.003, PMID: 26042927.
PeterP.LilliengrenPeterP. i inni, Efficacy of experiential dynamic therapy for psychiatric conditions: a meta-analysis of randomized controlled trials, „Psychotherapy”, 53 (1), 2016, s. 90–104, DOI: 10.1037/pst0000024, PMID: 26390013.
AnnaA.HuguetAnnaA. i inni, A systematic review and meta-analysis on the efficacy of Internet-delivered behavioral activation, „Journal of Affective Disorders”, 235, 2018, s. 27–38, DOI: 10.1016/j.jad.2018.02.073, PMID: 29649708.
IsabelleI.Soucy-ChartierIsabelleI., Martin D.M.D.ProvencherMartin D.M.D., Behavioural activation for depression: efficacy, effectiveness and dissemination, „Journal of Affective Disorders”, 145 (3), 2013, s. 292–299, DOI: 10.1016/j.jad.2012.07.023, PMID: 22884236.
Stefan G.S.G.HofmannStefan G.S.G. i inni, The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review, „Journal of Consulting and Clinical Psychology”, 78 (2), 2010, s. 169–183, DOI: 10.1037/a0018555, PMID: 20350028, PMCID: PMC2848393.
AlbertoA.ChiesaAlbertoA., AlessandroA.SerrettiAlessandroA., Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis, „Psychiatry Research”, 187 (3), 2011, s. 441–453, DOI: 10.1016/j.psychres.2010.08.011, PMID: 20846726.
BassamB.KhouryBassamB. i inni, Mindfulness-based therapy: a comprehensive meta-analysis, „Clinical Psychology Review”, 33 (6), 2013, s. 763–771, DOI: 10.1016/j.cpr.2013.05.005, PMID: 23796855.
Mark B.M.B.PowersMark B.M.B., Maarten B. Zum Vörde SiveM.B.Z.V.S.VördingMaarten B. Zum Vörde SiveM.B.Z.V.S., Paul M.G.P.M.G.EmmelkampPaul M.G.P.M.G., Acceptance and Commitment Therapy: a meta-analytic review, „Psychotherapy and Psychosomatics”, 78 (2), 2009, s. 73–80, DOI: 10.1159/000190790, PMID: 19142046.
Lars-GöranL.G.ÖstLars-GöranL.G., The efficacy of Acceptance and Commitment Therapy: an updated systematic review and meta-analysis, „Behaviour Research and Therapy”, 61, 2014, s. 105–121, DOI: 10.1016/j.brat.2014.07.018, PMID: 25193001.
ThomasT.HackerThomasT., PaulP.StonePaulP., AngusA.MacBethAngusA., Acceptance and commitment therapy – do we know enough? Cumulative and sequential meta-analyses of randomized controlled trials, „Journal of Affective Disorders”, 190, 2016, s. 551–565, DOI: 10.1016/j.jad.2015.10.053, PMID: 26571105.
NicolineN.NormannNicolineN., Arnold A.P. vanA.A.P.EmmerikArnold A.P. vanA.A.P., NexhmedinN.MorinaNexhmedinN., The efficacy of metacognitive therapy for anxiety and depression: a meta-analytic review, „Depression and Anxiety”, 31 (5), 2014, s. 402–411, DOI: 10.1002/da.22273, PMID: 24756930.
Samantha A.S.A.MasleySamantha A.S.A. i inni, A systematic review of the evidence base for schema therapy, „Cognitive Behaviour Therapy”, 41 (3), 2012, s. 185–202, DOI: 10.1080/16506073.2011.614274, PMID: 22074317.
Lauren S.L.S.HallionLauren S.L.S., Ayelet MeronA.M.RuscioAyelet MeronA.M., A meta-analysis of the effect of cognitive bias modification on anxiety and depression, „Psychological Bulletin”, 137 (6), 2011, s. 940–958, DOI: 10.1037/a0024355, PMID: 21728399.
Cuijpers i inni, Psychological treatment of depression: Results of a series of meta-analyses, „Nordic Journal of Psychiatry”, 65 (6), 2011, s. 354–364, DOI: 10.3109/08039488.2011.596570, PMID: 21770842.
Ioana A.I.A.CristeaIoana A.I.A. i inni, Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: Meta-analysis, „The British Journal of Psychiatry”, 210 (1), 2017, s. 16–23, DOI: 10.1192/bjp.bp.115.179275, PMID: 27810891.
David F.D.F.TolinDavid F.D.F., Can cognitive behavioral therapy for anxiety and depression be improved with pharmacotherapy? A meta-analysis, „Psychiatric Clinics of North America”, 40 (4), 2017, s. 715–738, DOI: 10.1016/j.psc.2017.08.007, PMID: 29080596.
ChristophCh.FlückigerChristophCh. i inni, Enduring effects of evidence-based psychotherapies in acute depression and anxiety disorders versus treatment as usual at follow-up – A longitudinal meta-analysis, „Clinical Psychology Review”, 34 (5), 2014, s. 367–375, DOI: 10.1016/j.cpr.2014.05.001, PMID: 24927168.
EiriniE.KaryotakiEiriniE. i inni, The long-term efficacy of acute-phase psychotherapy for depression: a meta-analysis of randomized trials, „Depression and Anxiety”, 33 (5), 2016, s. 370–383, DOI: 10.1002/da.22491, PMID: 27000501.
B. Dierckx, W.T. Heijnen, W.W. van den Broek, T.K. Birkenhäger. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. „Bipolar Disord”. 14 (2), s. 146–150, 2012. DOI: 10.1111/j.1399-5618.2012.00997.x. PMID: 22420590.
DaliaD.Al-KarawiDaliaD., LuqmanL.JubairLuqmanL., Bright light therapy for nonseasonal depression: Meta-analysis of clinical trials, „Journal of Affective Disorders”, 198, 2016, s. 64–71, DOI: 10.1016/j.jad.2016.03.016, PMID: 27011361.
M.T.M.T.BerlimM.T.M.T., F. Van denF.V.EyndeF. Van denF.V., Z.J.Z.J.DaskalakisZ.J.Z.J., A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression, „Psychological Medicine”, 43 (11), 2013, s. 2245–2254, DOI: 10.1017/S0033291712002802, PMID: 23200131.
Jian-junJ.ChenJian-junJ. i inni, Bilateral vs. unilateral repetitive transcranial magnetic stimulation in treating major depression: A meta-analysis of randomized controlled trials, „Psychiatry Research”, 219 (1), 2014, s. 51–57, DOI: 10.1016/j.psychres.2014.05.010, PMID: 24889845.
Jian-junJ.ChenJian-junJ. i inni, Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: A systematic review and multiple-treatments meta-analysis, „Behavioural Brain Research”, 320, 2017, s. 30–36, DOI: 10.1016/j.bbr.2016.11.028, PMID: 27876667.
Jean-PascalJ.P.LefaucheurJean-PascalJ.P. i inni, Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS), „Clinical Neurophysiology”, 128 (1), 2017, s. 56–92, DOI: 10.1016/j.clinph.2016.10.087, PMID: 27866120.
Donel M.D.M.MartinDonel M.D.M. i inni, Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: An individual patient data meta-analysis of randomised, sham-controlled trials, „Neuroscience & Biobehavioral Reviews”, 90, 2018, s. 137–145, DOI: 10.1016/j.neubiorev.2018.04.008, PMID: 29660416.
Anna Maratos, Christian Gold, Xu Wang et al.. Music therapy for depression. „Cochrane Database of Systematic Reviews”, s. 1059–1066, 2008. DOI: 10.1002/14651858.CD004517.pub3. PMID: 29144545.Sprawdź autora:1.
SiriS.KvamSiriS. i inni, Exercise as a treatment for depression: A meta-analysis, „Journal of Affective Disorders”, 202, 2016, s. 67–86, DOI: 10.1016/j.jad.2016.03.063, PMID: 27253219.
J. Luigjes, B.P. de Kwaasteniet, P.P. de Koning, M.S. Oudijn i inni. Surgery for psychiatric disorders. „World Neurosurg”. 80 (3–4), s. S31.e17-S31.e28, 2013. DOI: 10.1016/j.wneu.2012.03.009. PMID: 22465369.
Julie MagnoJ.M.ZitoJulie MagnoJ.M. i inni, Rising prevalence of antidepressants among US youths, „Pediatrics”, 109 (5), 2002, s. 721–727, DOI: 10.1542/peds.109.5.721, PMID: 11986427.
S. Ilyas, J. Moncrieff. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. „Br J Psychiatry”. 200 (5), s. 393–398, 2012. DOI: 10.1192/bjp.bp.111.104257. PMID: 22442100.
W.A. Vega, M.A. Rodriguez, A. Ang. Addressing stigma of depression in Latino primary care patients. „Gen Hosp Psychiatry”. 32 (2). s. 182–191. DOI: 10.1016/j.genhosppsych.2009.10.008. PMID: 20302993.
João MaurícioJ.M.Castaldelli-MaiaJoão MaurícioJ.M. i inni, Perceptions of and attitudes toward antidepressants: stigma attached to their use-a review, „The Journal of Nervous and Mental Disease”, 199 (11), 2011, s. 866–871, DOI: 10.1097/NMD.0b013e3182388950, PMID: 22048139.
M.C. Angermeyer, M. Beck, S. Dietrich, A. Holzinger. The stigma of mental illness: patients’ anticipations and experiences. „Int J Soc Psychiatry”. 50 (2), s. 153–162, 2004. DOI: 10.1177/0020764004043115. PMID: 15293432.
MagdalenaM.Podogrodzka-NiellMagdalenaM., MagdalenaM.TyszkowskaMagdalenaM., Stygmatyzacja na drodze zdrowienia w chorobach psychicznych – czynniki związane z funkcjonowaniem społecznym / Stigmatization on the way to recovery in mental illness – the factors associated with social functioning, „Psychiatria Polska”, 48 (6), 2014, s. 1201–1211, DOI: 10.12740/PP/20364, PMID: 25717489(pol. • ang.).
Krzysztof Walczewski, Łukasz Müldner-Nieckowski, Piotr Słowik, Wojciech Drath, Wojciech Kordas, Piotr Mężyński, Kamila Mizielińska Witkowska: Wyprzedzić Smutek – Program Profilaktyki Depresji. [dostęp 2015-05-18].
George A.G.A.EbyGeorge A.G.A., Karen L.K.L.EbyKaren L.K.L., Magnesium for treatment-resistant depression: a review and hypothesis, „Medical Hypotheses”, 74 (4), 2010, s. 649–660, DOI: 10.1016/j.mehy.2009.10.051, ISSN0306-9877.
Miguel ÁngelM.Á.Martínez-GonzálezMiguel ÁngelM.Á., AlmudenaA.Sánchez-VillegasAlmudenaA., Magnesium intake and depression: the SUN cohort, „Magnesium Research”, 29 (3), 2016, s. 102–111, DOI: 10.1684/mrh.2016.0409, ISSN1952-4021, PMID: 27910807.